Global Medical Infusion Mixing Device Market to Reach USD 3.92 Billion by 2031 at 11.2% CAGR, Led by Baxter and Fresenius Kabi

The global medical infusion mixing device market, valued at USD 1,865 million in 2024, is projected to reach USD 3,921 million by 2031, expanding at a CAGR of 11.2% during the forecast period (2025-2031). According to the latest 2025 market research, this rapid growth is fueled by increasing demand for automated and precise drug administration, driven by advancements in infusion technology, the rise of home healthcare, and integration of digital monitoring systems.
Market Overview and Segmentation
In 2024, global production of medical infusion mixing devices reached approximately 621 thousand units, with an average market price of USD 3,000 per unit. Medical infusion mixing devices are designed to automatically and safely mix multiple drug solutions during infusion therapy, ensuring accuracy and efficiency in hospital and critical care settings.
Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart)https://www.qyresearch.com/sample/4842976
Key Players and Competitive Landscape
Leading global manufacturers include:
• Baxter International
• B. Braun Melsungen
• Fresenius Kabi
• Becton Dickinson
• Smiths Medical
• ICU Medical
• Terumo Corporation
• Nipro Corporation
• Hospira
• Medtronic
• Mindray
• Weigao Group
• Codan Medical
• Grifols
• Vygon Group
• Omnicell
• Micrel Medical
• West Pharmaceutical Services
Product Profiles: Selected Medical Infusion Mixing & Pump Devices
ICU Medical - Plum SoloTM Precision IV Pump
• Company: ICU Medical
• Product: Plum SoloTM single channel precision IV pump
• FDA Clearance: April 7, 2025 (510(k) K242114)
• Accuracy: ±3 % under real world conditions using patented cassette technology
• Display: 7-inch full color touchscreen with safety feedback
• Supports: whole blood, blood products, variable temperature and elevation conditions
Baxter - NOVUM IQ Syringe Infusion System
• Company: Baxter International
• Product: NOVUM IQ syringe infusion pump
• Flow rate precision:
o 0.01-99.99 mL/hr (±0.01 mL/hr)
o 100-999.9 mL/hr (±0.1 mL/hr)
o 1,000-1,200 mL/hr (±1 mL/hr)
• Syringe capacity: 1-60 mL, maximum volume 999 mL; KVO configured to keep infusion until empty
• Dose modes: supports mg/kg, mL/kg, dose/time, bolus/loading, rate changes, body weight/BSA inputs
Fresenius Kabi - Ivenix Infusion System
• Company: Fresenius Kabi
• Product: IvenixTM Infusion System (volumetric/pneumatic pump)
• EMR Integration: full connectivity with electronic medical records
• Pumping tech: advanced pneumatic flow control for precise medication delivery and safety
• Safety features: prevention of medication errors, air embolism, over infusion alerts
B. Braun - PINNACLE® Single Chamber Mixing Container (EVA, 1000 mL)
• Company: B. Braun Melsungen
• Product: PINNACLE® EVA single chamber 3 in 1 mixing container (1,000 mL)
• Purpose: gravity based total parenteral nutrition (TPN) mixing and transfer, closed system
• Advantages: streamlines safe TPN delivery, reduces contamination risk, simplified compounding
Medtronic - ExtendedTM Infusion Set (Insulin Delivery)
• Company: Medtronic
• Product: ExtendedTM infusion set and reservoir for insulin pumps
• Wear duration: up to 7 days per set vs typical 2-3 days (one change per week)
• Target users: individuals with dexterity issues, needle anxiety, active lifestyles
• Features: soft cannula, hypo allergenic adhesive, low profile, widely used with MiniMed systems
Market Segmentation by Type
• Automatic Infusion Mixing Devices
• Manual Infusion Mixing Devices
Market Segmentation by Application
• Hospital Clinical Departments
• Intensive Care Units
• Operating Rooms
• Emergency & Transport
• Others
Regional Insights
North America, Europe, and Asia-Pacific remain the dominant markets. Asia-Pacific is expected to demonstrate the fastest growth rate due to rising hospital construction, expanding healthcare infrastructure, and increased adoption of automated infusion solutions. Meanwhile, U.S. tariff adjustments in 2025 have introduced supply chain uncertainties, prompting manufacturers to explore diversified sourcing and regional assembly strategies.
Latest Trends and Technological Innovations
Automation and Connectivity
In 2025, the infusion mixing device market is experiencing a strong pivot toward fully automated systems integrated within hospital IT infrastructures. Smart pumps equipped with drug libraries, dose error reduction software, and wireless communication capabilities not only minimize human error, but also streamline workflows across clinical teams. Hospitals increasingly require infusion pumps that communicate bi directionally with EMR/EHR systems via Wi Fi or Bluetooth, enabling remote monitoring, fleet oversight, and real time alerts.
Remote Monitoring & Home Infusion
Remote patient monitoring (RPM) technologies are now widely deployed, enabling infusion devices to transmit usage data, vital signs, and device status directly to centralized monitoring platforms. This capability supports telehealth workflows and improves patient safety outside acute care settings. The broader infusion pump market-which reached approximately USD 11.3 billion in 2025-is growing rapidly, driven by home based care and ambulatory infusion programs with connected device support.
Precision Therapy and Pressure Enabled Drug Delivery (PEDD)
Emerging pressure enabled drug delivery technologies are gaining traction, especially for high viscosity biologics and targeted therapies requiring controlled pressure and flow profiles. These systems improve absorption efficiency and dosing consistency through carefully engineered actuation mechanisms. Developers are customizing mechanical components-such as motors, gears, and actuators-to deliver consistent flow control for both IV and subcutaneous applications in wearable formats.
Miniaturization and Portable Applications
With increased demand in emergency medicine, transport, and home infusion, manufacturers are reducing device size and weight without compromising accuracy or safety. Miniaturized volumetric and syringe pumps now offer precision delivery in outpatient environments like ASCs and ambulatory infusion centers. Elastomeric infusion pumps-with capacity for continuous or variable-rate dispensing-are also being updated with improved interfaces and sustainability enhancements.
Industry Adoption & Market Dynamics
Integration trends are reshaping procurement decisions: hospitals now evaluate infusion devices based on interoperability with EMR systems, fleet management dashboards, and remote safety analytics. The advanced infusion systems segment (including volumetric and multi therapy pumps) is forecast to climb from USD 10.3 billion in 2025 to nearly USD 19.1 billion by 2035, with volumetric systems leading at 38 % market share. Regional leadership remains with North America, driven by regulatory incentives and high chronic illness prevalence, but Asia Pacific is the fastest growing region due to expanding healthcare infrastructure and home infusion adoption.
Request for Pre-Order Enquiry On This Report https://www.qyresearch.com/customize/4842976
Verified Downstream Customers
• Saint Francis Medical Center
• Mayo Clinic
• UCL Hospitals
• Cleveland Clinic
• Johns Hopkins Hospital
• Massachusetts General Hospital
• Mount Sinai Health System
• Houston Methodist Hospital
• Stanford Health Care
• Toronto General Hospital
• Charité - Universitätsmedizin Berlin
• Singapore General Hospital
• Siriraj Hospital
• Royal Prince Alfred Hospital
• Hospital Israelita Albert Einstein
Market Outlook
With an anticipated 11.2% CAGR through 2031, the medical infusion mixing device market is positioned for robust expansion. Companies that prioritize automation, connectivity, and supply chain resilience will lead in both hospital and home infusion markets. Growing adoption of portable, accurate, and EMR-integrated solutions indicates that precision and digital transformation will remain at the forefront of market competition.

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: key insights, key emerging trends, etc.
Chapter 3: Manufacturers competitive analysis, detailed analysis of the product manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 5 & 6: Sales, revenue of the product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: The main points and conclusions of the report.

Contact Details
Tel: +1 626 2952 442 ; +41 765899438(Tel & Whatsapp); +86-1082945717
Email: john@qyresearch.com; global@qyresearch.com
Website: www.qyresearch.com

About us:
QY Research has established close partnerships with over 71,000 global leading players. With more than 20,000 industry experts worldwide, we maintain a strong global network to efficiently gather insights and raw data.

Our 36-step verification system ensures the reliability and quality of our data. With over 2 million reports, we have become the world's largest market report vendor. Our global database spans more than 2,000 sources and covers data from most countries, including import and export details.

We have partners in over 160 countries, providing comprehensive coverage of both sales and research networks. A 90% client return rate and long-term cooperation with key partners demonstrate the high level of service and quality QY Research delivers.

More than 30 IPOs and over 5,000 global media outlets and major corporations have used our data, solidifying QY Research as a global leader in data supply. We are committed to delivering services that exceed both client and societal expectations.

This release was published on openPR.